7. Intangible and Other Assets

The following table summarizes intangibles and other assets—net as of fiscal year end 2011 and 2010, respectively (in thousands):


			2011				2010
	Useful Lives		Carrying Amount		Accumulated Amortization		Carrying Amount		Accumulated Amortization
Intangibles—subject to amortization:
Trademarks		10 yrs.	$	4,121	$	2,109	$	2,666	$	1,795
Customer lists		9yrs.		7,636		7,274		7,937		6,963
Patents		14-20 yrs.		773		394		775		349
Other		7-20 yrs.		193		190		194		187

Total intangibles—subject to amortization				12,723		9,967		11,572		9,294
Intangibles—not subject to amortization:
Trade names				18,936				18,938
Other assets:
Key money deposits				31,804		10,291		22,973		7,720
Other deposits				13,685				11,991
Deferred compensation plan assets				2,897				3,295
Deferred tax asset				4,875				926
Restricted cash				2,114				0
Other				10,868		3,748		5,689		2,633

Total other assets				66,243		14,039		44,874		10,353

Total intangible and other assets			$	97,902	$	24,006	$	75,384	$	19,647

Total intangible and other assets—net					$	73,896			$	55,737

Amortization expense for intangible assets, key money deposits and other assets was approximately $5.1 million, $5.9 million and $4.4 million for fiscal years 2011, 2010 and 2009, respectively. Estimated aggregate future amortization expense for intangible assets, key money deposits and other assets is estimated as follows (in thousands):


Fiscal Year	Amortization Expense
2012	$	5,254
2013		4,478
2014		3,990
2015		3,496
2016		2,936

As noted in Note 1, the Company performed its annual impairment test of certain trade names. At December 31, 2011, the estimated fair value of the Company's MICHELE and ZODIAC tradenames exceeded the carrying cost of these indefinite-lived intangible assets, therefore no impairment charges were recorded. The OYZTERBAY trade name carrying value was written down to zero in fiscal year 2010, therefore no impairment testing of that trade name was performed in fiscal year 2011. During fiscal year 2010, the Company's annual impairment analysis resulted in net of tax impairment charges of $837,000 and $789,000 to the OYZTERBAY and ZODIAC trade names, respectively. During fiscal year 2009, the Company's annual impairment analysis resulted in net of tax impairment charges of $0.4 million and $1.8 million to the OYZTERBAY and ZODIAC trade names, respectively. The ZODIAC and OYZTERBAY trade names are reported within the Europe wholesale segment.